Great article highlighting DMD and the UK's new initiative to speed up drug approvals in rare diseases.
Sentiment: Strong Buy
Hey FDA can you explain slide 18? This drug clearly works
Sorry AZN not GSK
Smart move by AMRN, Lol!
Awful, scripts #'s are just awful
Been in the biz a long time. I specialize in companion dx, CLVS will get there.
They are neighbors but I think Sanofi or Vertex would be a better fit
$1.78 , next stop $1.50
Be there soon
wow, what a day
lol you mean $0.30 in 18 months
it's non existant, no buyers and no sellers
I hate analysts
In new note to investors
This company is in big trouble
Nothing monumental today but still pretty good
Nailed it yet again